Press Room

Event

12th DPI China Technology Conference

Start
Thursday, March 27, 2025 - 09:00
End
Friday, March 28, 2025 - 18:00
Location: Nanjing, China
DPI China 2025

Looking for a complete One-Site Solution for your inhalation and nasal therapies? 
Meet Hovione at the 12th DPI China Technology Conference! 

Hovione offers customized high-performance APIs, particle engineering and formulation along with a full range of highly specialized, patented, and innovative devices, all in one site. 

Don’t miss the chance to speak with our Inhalation Experts in Nanjing. Our team is ready to share how this integration on a single site can support your project.

Session Title:
From Particle to Drug Delivery: Integrated Platforms for Respiratory Drug Products
March 28th, 2025
Session III, 11:30 -12:00

Speaker: 
João Pires, PhD - RD Senior Manager, Inhalation and Advanced Drug Delivery at Hovione

Description: This presentation covers the latest trends in pulmonary and nasal formulations and explores how Hovione’s integrated approach addresses the challenges in developing new therapeutics. From innovative formulation and device platforms to a unique set of expertise and capabilities, the session will guide the audience through the drug development cycle of dry powder formulations. It will highlight how an integrated strategy - encompassing formulation, process, and device optimization - can lead to better and more robust respiratory drug products.

Key learnings:

  • Discover the latest advancements in formulation, particle design, and device platforms that address the growing complexity of respiratory formulations and enable next-generation therapeutics
  • Learn how a seamless integration of formulation, process, and device in the drug development cycle can streamline development, reduce risks, and achieve better products

Delivering solutions every breath of the way.

We live and breathe innovation for the successful delivery of your inhalation and nasal therapies.

Schedule a meeting today.

 

 

 

Also in the Press Room

See All

CDMO Hovione and biotechnology company Firstgene Life Sciences (of Xlife Sciences) have collaborated to advance Hovione’s drug delivery platform for the targeted treatment of Hepatocellular Carcinoma (HCC). “We are proud to advance the development of innovative oncology treatments that address a critical unmet need for precision gene expression at the tissue level,” said Hovione CEO Dr Jean-Luc Herbeaux. The virus-like particle technology will be engineered and functionalised for the specific carcinoma cell type using therapeutically validated AAVs, including a novel primer compound. Hovione will be responsible for molecular engineering, the supply of tailor-made virus-like particles and the execution of proof-of-concept studies. “HCC, the most common liver cancer and a leading cause of cancer-related death, continues to represent a major unmet medical need,” said Firstgene managing director Dr Alexander Zink. “The combination of Hovione’s expertise in complex chemistry and particle engineering and the commercialisation expertise of Xlife Sciences positions Firstgene well to offer patients potential new safe and effective therapy options.”   Read the full article at scientistlive.com    

Press Clipping
Scientist Live, 12 May 2025

Partnership advances liver cancer treatment

May 12, 2025

Dear Customer, As you may be aware, Portugal and Spain experienced yesterday, April 28 (at approximately 11:30) a widespread power outage. This unexpected event, beyond our control, affected the normal activities at our sites in Portugal. In response, we promptly activated our contingency protocols for this type of situation, prioritizing the safety of facilities and personnel. All ongoing processes were taken to safe hold points, and no new processes were initiated. Our backup power generators ensured continuity of critical functions throughout the duration of the outage, which lasted approximately 11 hours, until the power from the grid was restored at the site. The site began resuming operations gradually through the night making sure all systems being restarted safely and verified to be in good working conditions. We anticipate that most activities will be fully resumed during today. Should you have any specific questions regarding your product or project, we kindly encourage you to contact your Account Manager or Project Manager, who will be glad to assist you. We sincerely appreciate your understanding and continued partnership.      

News
News release, 29 April 2025

Widespread power outage in Portugal - Message to our clients

Apr 29, 2025

In a recent appearance on CNN Portugal’s Pitch – Brand & Content program, Ilda Ventura, Senior Vice President of Human Resources at Hovione, highlighted a powerful reality: 55% of our employees in Science, Technology, Engineering, and Mathematics (STEM) roles are women. At Hovione, we’re proud to foster an environment where women in science thrive - leading innovation, driving progress, and shaping the future of healthcare. But our commitment goes beyond numbers - it’s about creating the right conditions for scientific talent to grow, equally and globally. “I am proud to say that, in our company, there is no gender pay gap between men and women. We empower everyone. Our female and male scientists are all working to find more sustainable, faster, and more productive ways to achieve victories over diseases.” - Ilda Ventura Watch the full edition to learn more about our commitment to women in science at CNNPortugal.pt  (Language: Portuguese)  

Press Clipping
CNN Portugal, 15 March 2025

Ilda Ventura broadcasted on CNN Portugal

Mar 15, 2025

Also in Events

See All